Getagraph.com logo
S&P 500
(0.00%) 5 187.67 points
Dow Jones
(0.44%) 39 056 points
Nasdaq
(-0.18%) 16 303 points
Oil
(1.07%) $79.22
Gas
(-1.13%) $2.18
Gold
(-0.34%) $2 316.40
Silver
(0.08%) $27.57
Platinum
(-0.23%) $986.15
USD/EUR
(0.12%) $0.931
USD/NOK
(0.06%) $10.91
USD/GBP
(0.12%) $0.800
USD/RUB
(0.19%) $91.62

リアルタイムの更新： Eris Lifesciences Limited [ERIS.NS]

取引所: NSE セクター: Healthcare 産業: Drug Manufacturers—Specialty & Generic
最終更新日時8 5月 2024 @ 19:00
25% discount on Stockinvest.us - Use code: Podcast

0.53% INR 873.35

Live Chart Being Loaded With Signals

Commentary (8 5月 2024 @ 19:00):

Eris Lifesciences Limited manufactures, markets, and distributes pharmaceutical products in India. It offers various branded formulations in various therapeutic areas, such as cardiovascular, anti–diabetes, anti-infective, antipyretics, vitamins/nutrients, gastroenterology, respiratory, gynecology, pediatrics, neurology, psychiatry, and pain/analgesics, as well as in-vitro fertilization, cosmetology, and dermatology...

Stats
本日の出来高 102 187
平均出来高 178 639
時価総額 118.82B
EPS INR0 ( 2024-02-13 )
次の収益日 ( INR0 ) 2024-05-14
Last Dividend INR7.35 ( 2022-08-11 )
Next Dividend INR0 ( N/A )
P/E 30.84
ATR14 INR0.520 (0.06%)

ボリューム 相関

長: 0.25 (neutral)
短: 0.19 (neutral)
Signal:(52.761) Neutral

Eris Lifesciences Limited 相関

10 最も正の相関
NECCLTD.NS0.892
BINDALAGRO.NS0.889
ROSSARI.NS0.887
SETFNIF50.NS0.882
AXISNIFTY.NS0.881
INDIANHUME.NS0.881
KOTAKNIFTY.NS0.88
ICICINIFTY.NS0.879
LICNFNHGP.NS0.879
BSLNIFTY.NS0.878
10 最も負の相関
SOMATEX.NS-0.88
JSL.NS-0.873
4THDIM.NS-0.859
KARDA.NS-0.839
BSELINFRA.NS-0.83
ISMTLTD.NS-0.819
GAIL.NS-0.817
KIRLFER.NS-0.815
FOSECOIND.NS-0.809
TARMAT.NS-0.804

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Eris Lifesciences Limited 相関 - 通貨/商品

The country flag 0.12
( neutral )
The country flag -0.11
( neutral )
The country flag 0.12
( neutral )
The country flag -0.09
( neutral )
The country flag -0.07
( neutral )
The country flag -0.25
( neutral )

Eris Lifesciences Limited 財務諸表

Annual 2022
収益: INR16.62B
総利益: INR13.09B (78.80 %)
EPS: INR28.10
FY 2022
収益: INR16.62B
総利益: INR13.09B (78.80 %)
EPS: INR28.10
FY 2022
収益: INR13.26B
総利益: INR10.65B (80.33 %)
EPS: INR29.89
FY 2021
収益: INR11.93B
総利益: INR9.51B (79.72 %)
EPS: INR26.16

Financial Reports:

No articles found.

Eris Lifesciences Limited Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
INR7.35
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A)

Eris Lifesciences Limited Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 3.44 - low (14.40%) | Divividend Growth Potential Score: 5.04 - Potential for dividend initiation, but uncertain (0.87%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend INR2.87 2020-03-19
Last Dividend INR7.35 2022-08-11
Next Dividend INR0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 4 --
Total Paid Out INR21.73 --
Avg. Dividend % Per Year 0.44% --
Score 1.99 --
Div. Sustainability Score 3.44
Div.Growth Potential Score 5.04
Div. Directional Score 4.24 --
Next Divdend (Est)
 (2024-10-30)
INR0 Estimate 0.00 %
Dividend Stability
0.06 Very Bad
Dividend Score
1.99
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2020 INR8.37 1.69%
2021 INR6.01 1.02%
2022 INR7.35 0.96%
2023 INR0 0.00%
2024 INR0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
RADICO.NS Dividend Junior 2023-09-14 Annually 22 0.24%
KHAICHEM.NS No Dividend Player 2023-07-21 Annually 5 0.32%
EMAMIPAP.NS Dividend Junior 2023-09-05 Annually 3 0.56%
AJANTPHARM.NS Dividend Knight 2023-08-04 Annually 23 0.57%
SUNTV.NS Dividend Knight 2023-08-22 Quarterly 19 1.94%
NAVNETEDUL.NS Dividend Junior 2023-08-07 Annually 22 1.10%
HPIL.NS Dividend Junior 2023-09-29 Annually 5 0.89%
CARERATING.NS Dividend Knight 2023-07-06 Semi-Annually 12 1.81%
ROSSELLIND.NS No Dividend Player 2023-07-20 Sporadic 12 0.12%
LFIC.NS Dividend Junior 2023-08-01 Annually 15 1.73%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.2101.5005.808.70[0 - 0.5]
returnOnAssetsTTM01.20000[0 - 0.3]
returnOnEquityTTM0.1671.5009.2610.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM00.800-5.00-4.00[1 - 3]
quickRatioTTM00.800-4.71-3.76[0.8 - 2.5]
cashRatioTTM01.500-1.111-1.667[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM8.081.0008.128.12[3 - 30]
operatingCashFlowPerShareTTM19.152.003.627.23[0 - 30]
freeCashFlowPerShareTTM19.152.000.4240.847[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.8181.00010.0010.00[0.2 - 0.8]
operatingProfitMarginTTM0.2661.0006.676.67[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score3.44

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM30.601.0007.010[1 - 100]
returnOnEquityTTM0.1672.509.5210.00[0.1 - 1.5]
freeCashFlowPerShareTTM19.152.003.620.847[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM19.152.003.627.23[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM2.151.50010.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1421.0008.960[0.1 - 0.5]
Total Score5.04

Eris Lifesciences Limited

Eris Lifesciences Limited manufactures, markets, and distributes pharmaceutical products in India. It offers various branded formulations in various therapeutic areas, such as cardiovascular, anti–diabetes, anti-infective, antipyretics, vitamins/nutrients, gastroenterology, respiratory, gynecology, pediatrics, neurology, psychiatry, and pain/analgesics, as well as in-vitro fertilization, cosmetology, and dermatology. Eris Lifesciences Limited was incorporated in 2007 and is based in Ahmedabad, India.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。